XML 28 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
Description of Business and Summary of Significant Accounting Policies - Additional Information I (Detail) (USD $)
Share data in Millions, unless otherwise specified
3 Months Ended 12 Months Ended 83 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 83 Months Ended 1 Months Ended 12 Months Ended 83 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 37 Months Ended 83 Months Ended 1 Months Ended 12 Months Ended 83 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2014
Dec. 31, 2012
Dec. 31, 2011
Mar. 31, 2014
Dec. 31, 2013
sqft
Mar. 31, 2014
Third party [Member]
Oct. 31, 2011
Research and Development Services [Member]
Mar. 31, 2013
Research and Development Services [Member]
Mar. 31, 2012
Research and Development Services [Member]
Mar. 31, 2014
Research and Development Services [Member]
Dec. 31, 2012
Research and Development Services [Member]
Dec. 31, 2011
Research and Development Services [Member]
Mar. 31, 2014
Research and Development Services [Member]
Dec. 31, 2010
12 month research contract agreement [Member]
Dec. 31, 2012
12 month research contract agreement [Member]
Dec. 31, 2011
12 month research contract agreement [Member]
Mar. 31, 2014
12 month research contract agreement [Member]
Mar. 31, 2014
U.S. Treasury [Member]
Dec. 31, 2010
U.S. Treasury [Member]
Grants
Mar. 31, 2013
NHLBI [Member]
Mar. 31, 2012
NHLBI [Member]
Mar. 31, 2014
NHLBI [Member]
Dec. 31, 2012
NHLBI [Member]
Dec. 31, 2011
NHLBI [Member]
Dec. 31, 2012
NHLBI [Member]
Grants
Mar. 31, 2014
NHLBI [Member]
Aug. 31, 2013
Private, not-for-profit organization [Member]
Mar. 31, 2014
Private, not-for-profit organization [Member]
Mar. 31, 2014
Private, not-for-profit organization [Member]
Dec. 31, 2013
Maximum [Member]
Mar. 31, 2014
Maximum [Member]
Mar. 31, 2014
Minimum [Member]
Significant Accounting Policies Related To Business Acquisition Revenue Recognition And Earnings Per Share [Line Items]                                                                    
Maturity of highly liquid investment                                                               90 days    
Restricted cash $ 88,000   $ 79,000 $ 88,000   $ 79,000                                                        
Restricted cash held in certificates of deposit 38,300   78,800 38,300   78,800                                                        
Increase in rented area             15,268                                                      
Additional restricted cash 50,000     50,000                                                            
Allowance for doubtful amounts     0     0                                                        
Inventory of raw materials, net of reserves 88,000   63,000 104,000   63,000                                                        
Inventory of finished goods       196,000                                                            
Inventory of work-in-progress       60,000                                                            
Obsolete inventory reserve 0   31,000 0   31,000                                                        
Estimated useful life of the fixed assets     The estimated useful lives of the fixed assets range between two and five years.                                                              
Useful life of fixed assets, range                                                                 5 years 2 years
Impairment of long-lived assets     0                                                              
Deferred revenue related to its collaborative research programs 53,000   13,000     13,000       62,000   17,000 0   17,000                                      
Term of research contract agreement with third party                               12 months                                    
Research and development services on a fixed-fee basis                 1,365,000             600,000                                    
Total revenue recognized from inception on the contract 215,000 120,000 379,000 1,197,000 969,000 3,442,000                 1,405,000   150,000 450,000 600,000                              
Initial payment to company from agreement                 239,000                                                  
Remaining payments expected to occur over                 21 months                                                  
Fee for additional research and development services     135,000         40,000                                                    
Total potential contract value     1,500,000         1,405,000                                                    
Maximum amendment extended period remaining for payment of additional research and development services                       28 months                                            
Revenue related to research contract                   97,000 120,000 184,000 885,000 239,000                                        
Number of grants issued                                         2           3              
Revenue recognized under grants 117,000   131,000 162,000 57,000 1,074,000                           397,000   117,000 0 12,000 162,000 57,000 558,000 558,000 251,700 119,000 119,000      
Dilutive effect $ 0 $ 0 $ 0 $ 0 $ 0                                                          
Total common stock equivalents excluded from computing diluted net loss per share 8.9 25.8 7.7 15.2 6.4